FDA.reportPublic FDA data

lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet

RxCUI
672149
RxNorm name
lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Display name
lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Full name
lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:27

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TYKERBLAPATINIBNovartis Pharmaceuticals Corporationeee37f88-ec6a-4c30-b8aa-e2c71f93088c2026-01-27Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 672149
LapatinibLAPATINIBLupin Pharmaceuticals, Inc.50d0dd0c-7682-43d0-aa1b-ca26e9181aee2025-06-10Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 672149
LapatinibLAPATINIBAvKARE302a4346-a68d-af3e-e063-6294a90a4a6f2025-03-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 672149
LapatinibLAPATINIBTeva Pharmaceuticals, Inc.b09abf73-1eef-4e12-b400-c030d546d2232023-11-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 672149

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
eee37f88-ec6a-4c30-b8aa-e2c71f93088clapatinib 250 MG Oral Tablet [PSN] · lapatinib 250 MG Oral Tablet [SCD] · lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet [SY]314These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 200720260127
b09abf73-1eef-4e12-b400-c030d546d223lapatinib 250 MG Oral Tablet [PSN] · lapatinib 250 MG Oral Tablet [SCD] · lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet [SY]37These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. LAPATINIB tablets, for oral use Initial U.S. Approval: 200720231130
50d0dd0c-7682-43d0-aa1b-ca26e9181aeelapatinib 250 MG Oral Tablet [PSN] · lapatinib 250 MG Oral Tablet [SCD] · lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet [SY]34These highlights do not include all the information needed to use lapatinib tablets safely and effectively. See full prescribing information for lapatinib tablets. LAPATINIB tablets, for oral use Initial U.S. Approval: 200720250610
302a4346-a68d-af3e-e063-6294a90a4a6flapatinib 250 MG Oral Tablet [PSN] · lapatinib 250 MG Oral Tablet [SCD] · lapatinib 250 MG (as lapatinib ditosylate 398 MG) Oral Tablet [SY]31LAPATINIB tablets, for oral use These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. Initial U.S. Approval: 200720250312